Dr Abel Abrego Salas Sr, MD | |
709 Tolar Highway, Tolar, TX 76476 | |
(817) 706-6313 | |
Not Available |
Full Name | Dr Abel Abrego Salas Sr |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 709 Tolar Highway, Tolar, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508523408 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | E836 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Abel Abrego Salas Sr, MD Po Box 220, Tolar, TX 76476-0220 Ph: (817) 706-6313 | Dr Abel Abrego Salas Sr, MD 709 Tolar Highway, Tolar, TX 76476 Ph: (817) 706-6313 |
News Archive
Republican lawmakers on the state level are largely against the new health reform law—but they aren't against all of the behemoth legislation. Virginia dominated headlines this week when a federal judge ruled the individual mandate to buy insurance unconstitutional on Monday. Much less noticed: the very next day, a task force appointed by Republican Gov. Bob McDonnell recommended that the state implement a health insurance exchange earlier than federal guidelines require (Kliff, 12/16).
"The United Nations on Thursday announced that it will allocate $55 million to bolster operations in eight countries with neglected humanitarian emergencies," the U.N. News Centre reports, adding, "Afghanistan, Cameroon, Colombia, the Democratic Republic of Congo (DRC), Ethiopia, Madagascar, Sri Lanka and Sudan will all receive funds from the Central Emergency Response Fund (CERF) to help provide food, water, health and other basic services."
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced the completion of patient enrollment in a Phase II clinical trial of ImmunoPulse for metastatic melanoma patients.
Invasive lobular carcinoma (ILC) of the breast can be treated with breast conserving surgery (BCT), as is invasive ductal carcinoma (IDC), without greater future risk of radical surgical treatment or additional surgeries, according to a new study.
It may soon be possible to take a simple blood test and predict whether or not someone has low levels of a particular molecule, predisposing them to the development of Type 2 diabetes.
› Verified 5 days ago